Madison Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.47M Buy
5,678
+411
+8% +$186K 0.52% 63
2023
Q2
$2.34M Buy
5,267
+200
+4% +$92.3K 0.47% 65
2023
Q1
$2.33M Buy
5,067
+342
+7% +$163K 0.5% 65
2022
Q4
$2.42M Hold
4,725
0.55% 58
2022
Q3
$2.15M Sell
4,725
-2
-0% -$957 0.53% 56
2022
Q2
$2.28M Hold
4,727
0.55% 55
2022
Q1
$2.32M Buy
4,727
+70
+2% +$32K 0.49% 57
2021
Q4
$2.16M Hold
4,657
0.43% 63
2021
Q3
$1.74M Hold
4,657
0.38% 64
2021
Q2
$1.78M Buy
4,657
+4
+0.1% +$1.53K 0.39% 65
2021
Q1
$1.67M Hold
4,653
0.41% 61
2020
Q4
$1.49M Buy
4,653
+3,475
+295% +$1.07M 0.39% 56
2020
Q3
$316K Hold
1,178
0.09% 109
2020
Q2
$310K Hold
1,178
0.1% 100
2020
Q1
$267K Hold
1,178
0.11% 99
2019
Q4
$356K Buy
+1,178
New +$324K 0.1% 110

Other funds holding ELV

Madison Wealth Management's ELV Position: Q3 2023 in Review

Madison Wealth Management increased its Elevance Health (ELV) stake by 7.8% in Q3 2023, buying an estimated $186K and bringing the position to 5,678 shares worth $2.47M. The position accounts for 0.52% of the portfolio, ranked #63.

Madison Wealth Management first reported a position in ELV in Q4 2019 and has held it in 16 quarters since. 1,524 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Madison Wealth Management held 5,678 shares of Elevance Health worth $2.47M as of Q3 2023.
  • Madison Wealth Management bought 411 Elevance Health shares in Q3 2023, an estimated $186K.
  • Elevance Health made up 0.52% of Madison Wealth Management's portfolio in Q3 2023, its #63 holding.
  • Madison Wealth Management first reported a position in Elevance Health in Q4 2019 and has held it in 16 quarters since.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Madison Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.